Insider Transactions in Q1 2021 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2021
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
13,438
-3.23%
|
$2,217,270
$165.55 P/Share
|
|
Feb 12
2021
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
33,021
+7.21%
|
-
|
|
Feb 12
2021
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,696
-2.53%
|
$939,840
$165.55 P/Share
|
|
Feb 12
2021
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,873
+5.33%
|
-
|
|
Feb 12
2021
|
Michael E Sneed EVP, Global Corp Aff & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,113
-2.4%
|
$513,645
$165.55 P/Share
|
|
Feb 12
2021
|
Michael E Sneed EVP, Global Corp Aff & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,211
+6.51%
|
-
|
|
Feb 12
2021
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
4,678
-6.82%
|
$771,870
$165.55 P/Share
|
|
Feb 12
2021
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
13,136
+15.45%
|
-
|
|
Feb 12
2021
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
14,317
-2.48%
|
$2,362,305
$165.55 P/Share
|
|
Feb 12
2021
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
35,062
+5.64%
|
-
|
|
Feb 12
2021
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
6,065
-2.52%
|
$1,000,725
$165.55 P/Share
|
|
Feb 12
2021
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
13,606
+5.26%
|
-
|
|
Feb 12
2021
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,494
-2.07%
|
$1,071,510
$165.55 P/Share
|
|
Feb 12
2021
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,444
+4.34%
|
-
|
|
Feb 12
2021
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,414
-3.23%
|
$728,310
$165.55 P/Share
|
|
Feb 12
2021
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,362
+6.91%
|
-
|
|
Feb 12
2021
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,456
-3.02%
|
$240,240
$165.55 P/Share
|
|
Feb 12
2021
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,086
+9.89%
|
-
|
|
Feb 12
2021
|
Robert J Decker VP Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
486
-1.67%
|
$80,190
$165.55 P/Share
|
|
Feb 12
2021
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,310
+4.36%
|
-
|
|
Feb 12
2021
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,706
-3.14%
|
$5,231,490
$165.55 P/Share
|
|
Feb 12
2021
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,105
+6.8%
|
-
|
|
Feb 12
2021
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
3,375
-4.01%
|
$556,875
$165.55 P/Share
|
|
Feb 12
2021
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
7,145
+8.0%
|
-
|